Technology

With 100 million chronic wound visits annually in the U.S., the wound care market will reach $20.5 billion by 2020. This includes Advanced Wound Care (chronic wounds, burns, etc.), Surgical Wound Care (scars, acute wounds, Mohs) and Cosmetic Wound Care (hair restoration). Current technologies are dated and show low efficacy, therefore the field has remained stagnant for more than two decades.

Our technology is built on an exclusive IP license with Johns Hopkins University, and comprises a unique mix of innovative products and techniques with a wide-range of regenerative medicine application, especially in the field of wound care.

EMR Scaffold

Filling the wound care void

Polymer-based scaffolds are extensively used in regenerative medicine applications because they provide a three-dimensional structure that simulates the native cell environment and extracellular matrix. Our first generation product is a novel biosynthetic scaffold for wound healing. Our scaffolds are highly tunable, meaning they can easily be tailored for specific wound healing applications. The incorporation of active ingredients including therapeutics, cells and growth factors allow for continuous scaffold evolution.

Topical Therapeutic

Targeting the wound care deficiencies

A family of well-known medications have been shown to profoundly and positively impact the healing of chronic wounds via several specific biological mechanisms. The research is based on prior evidence indicating that certain receptors are markedly increased in the wounds of older and diabetic patients. Increased levels of this pro-inflammatory receptor play a critical role in skin vulnerability, poor wound healing, and the development of chronic wounds.

Harness Our Technology

Want to learn more? Let’s talk